Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield By PTI NEW DELHI: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of the Covid-19 vaccine Covishield amid...
Serum Institute of India
COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla By PTI PUNE: Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster...
India’s first vaccine against cervical cancer to launch on September 1 By ANI NEW DELHI: The Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India’s first indigenously developed Quadrivalent...
Drug controller allows sale of Serum Institute’s cervical cancer vaccine By Express News Service NEW DELHI: The Drugs Controller General of India (DCGI) on Tuesday granted market authorisation to the Serum Institute of India...
Panel for emergency use approval to SII vaccination for 7-11 age group By Express News Service NEW DELHI: An expert panel advising the Central Drugs Standard Control Organisation (CDSCO) has recommended granting emergency use authorisation to...
Government panel recommends market authorisation for SII’s qHPV vaccine against cervical cancer 2 min read By PTI NEW DELHI: An expert panel of India’s central drug authority on Wednesday recommended granting of market authorisation to Serum Institute of India...
Millions of COVID vaccines unsold; stopped production since December 2021: Adar Poonawalla 3 min read By PTI MUMBAI: The Serum Institute of India has stopped producing the COVID-19 vaccine since the last day of December 2021 as it has...
Serum Institute, Bharat Biotech cut COVID vaccine prices for private hospitals to Rs 225 By PTI NEW DELHI: Vaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of...
DCGI’s EUA nod to SII’s Covovax for 12-17 years age group By PTI NEW DELHI: India’s drug regulator has granted restricted emergency use authorisation to Serum Institute’s COVID-19 vaccine Covovax for the 12-17 years age...
Government expert panel recommends regular market approval for Covishield, Covaxin By PTI NEW DELHI: An expert panel of India’s central drug authority on Wednesday recommended granting regular market approval to Covid vaccines Covishield and...
A huge memorial will be built in Chhatarpur to keep the memory of Maharaj Chhatrasal intact: CM Shri Chouhan 
‘Depicts Ashokan empire’: India downplays new Parliament building mural amid concerns in Nepal 
Prime Minister of Nepal Pushp Kamal Dahal Prachanda reaches Indore 
Villagers in Chhattisgarh attack forest staffers clearing encroachments in tiger reserve; three hurt